Alzamend Neuro, Inc. (ALZN) Dividend History

Alzamend Neuro, Inc. (ALZN) is a biopharmaceutical company focused on developing innovative treatments for neurodegenerative and psychiatric disorders. The company's pipeline primarily includes therapies targeting conditions such as Alzheimer's disease, with an emphasis on novel approaches to address unmet medical needs in mental health and neurological health.

3500 Lenox Rd. Ne, Atlanta, GA, 30326
Phone: 844-722-6333
Website: https://www.alzamend.com

Dividend History

Alzamend Neuro, Inc. currently does not pay dividends

Company News

  • The Dow Jones index closed lower by around 0.1% on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform. Aldeyra Therapeutics The Trade: Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) 10% owner Joseph Edelman acquired a total of 504,272 shares an average price of $3.84. To acquire these shares, it cost around $1.93 million. What’s Happening: On April ...

    Benzinga
    Featured Companies: ALDX RVP
  • The Securities and Exchange Commission has filed a lawsuit against eight individuals who allegedly earned $100 million via stock manipulation.

    MarketWatch
    Featured Companies: ABVC
  • Penny stocks to buy [or avoid] after Biogen Alzheimer's news. The post 4 Alzheimer’s Penny Stocks To Watch After Biogen Stock Explodes appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

    PennyStocks
    Featured Companies: ABOS BIIB DNA NRSN
  • The company hopes to advance the standard of care for people with dementia.

    The Motley Fool
  • Companies in the news are: PAYX, SPCE, ALZN, OG

    Zacks Investment Research
    Featured Companies: PAYX SPCE
Page data last updated 07/23/2025 16:19:58 UTC